Heck Capital Advisors LLC Makes New $1.65 Million Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Heck Capital Advisors LLC purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 3,260 shares of the healthcare conglomerate’s stock, valued at approximately $1,649,000.

Other institutional investors also recently bought and sold shares of the company. Austin Private Wealth LLC grew its holdings in shares of UnitedHealth Group by 16.4% during the fourth quarter. Austin Private Wealth LLC now owns 2,811 shares of the healthcare conglomerate’s stock worth $1,422,000 after buying an additional 396 shares in the last quarter. West Bancorporation Inc. grew its stake in UnitedHealth Group by 9.3% during the 4th quarter. West Bancorporation Inc. now owns 679 shares of the healthcare conglomerate’s stock valued at $343,000 after acquiring an additional 58 shares in the last quarter. Hamilton Point Investment Advisors LLC lifted its stake in UnitedHealth Group by 324.0% in the 4th quarter. Hamilton Point Investment Advisors LLC now owns 1,747 shares of the healthcare conglomerate’s stock worth $884,000 after purchasing an additional 1,335 shares in the last quarter. Country Trust Bank grew its position in shares of UnitedHealth Group by 23,347.9% in the fourth quarter. Country Trust Bank now owns 105,750 shares of the healthcare conglomerate’s stock valued at $53,495,000 after purchasing an additional 105,299 shares in the last quarter. Finally, Narus Financial Partners LLC lifted its position in UnitedHealth Group by 6.6% during the fourth quarter. Narus Financial Partners LLC now owns 770 shares of the healthcare conglomerate’s stock worth $390,000 after buying an additional 48 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Down 0.6 %

Shares of NYSE UNH opened at $542.30 on Friday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The stock has a market cap of $499.07 billion, a P/E ratio of 34.99, a PEG ratio of 1.46 and a beta of 0.62. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The business’s fifty day simple moving average is $537.14 and its 200-day simple moving average is $564.96.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the previous year, the company posted $5.83 earnings per share. The business’s revenue for the quarter was up 6.8% on a year-over-year basis. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 29.64 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.55%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction dated Friday, January 17th. The stock was acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 0.33% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a report on Friday, January 10th. UBS Group dropped their price target on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Deutsche Bank Aktiengesellschaft upped their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. TD Cowen lifted their target price on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research report on Friday, October 18th. Finally, KeyCorp reissued an “overweight” rating and set a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. One analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group has an average rating of “Buy” and a consensus target price of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.